|
Figure 1. Organizer-inducing factors activate Xhairy2b expression. A-F: Spatial expression patterns of Xhairy2b by whole-mount in situ hybridization at stage 10.5. Cleared embryos are shown in lateral view and dorsal is to the left. A: Uninjected control embryo. B-F: Ectopic induction of Xhairy2b expression in embryos ventrally microinjected with mRNAs encoding organizer-inducing factors. mRNAs of activin (B), BVg1 (C), Xnr1 (D), Xnr2 (E), and follistatin (F) were injected at the eight-cell stage. Arrowheads show the ectopic expression of Xhairy2b.
|
|
Figure 2. Ventral expression of Xhairy2b induces a secondary axis and inhibits ventralizing factors. A,B: Uninjected control embryo and Xhairy2b mRNA ventrally injected embryo, respectively, at stage 35. Xhairy2b mRNA ventral injection results in the induction of secondary axes lacking head structures (arrowhead). C: Transverse section of the embryo shown in B. Secondary axis (arrowhead) has neural tube and somitic mesoderm but lacks notochord. no, notochord, nt, neural tube, so, somite. D,Dâ²â²: Uninjected control embryos (D) and Xhairy2b mRNA (800 pg) ventrally injected embryos (Dâ²â²) are shown in vegetal view, dorsal side up at stage 10.5. Dâ²â²: Expression of organizer genes, follistatin (Dâ²), frzb1 (Eâ²), and admp (Fâ²) is ectopically induced by Xhairy2b (arrowheads). Gâ²: The expression of Xvent1 and Xvent2 in the ventral region (G,H) is reduced by Xhairy2b expression (Gâ²,Hâ², arrowheads).
|
|
Figure 3. Xhairy2b expression inhibits head formation and represses expression of some trunk and head organizer genes. Aâ²: Uninjected control embryos (A) and 800 pg of Xhairy2b mRNA dorsally injected embryos (Aâ²â²) at stage 30. The overexpression of Xhairy2b results in a deficit of the expression of nkx2.4 (A,Aâ²), otx2 (B,Bâ²), and en2 (C,Câ²) but not that of krox20 (D,Dâ²). Arrowheads indicate the remainder of the expression. E,Eâ²: β-catenin ventrally injected embryo (E) and β-catenin and Xhairy2b coinjected embryo (Eâ²). β-catenin expression induces a secondary axis containing a complete head (arrowhead in E), whereas the coinjection of Xhairy2b and β-catenin induces a secondary axis lacking head structures (arrowhead in Eâ²). Fâ²: Uninjected control embryo (F), 800 pg of Xhairy2b mRNA dorsally injected embryos (Fâ²â²), 400 pg of β-catenin mRNA ventrally injected embryos (L), and 400 pg of β-catenin and 800 pg of Xhairy2b mRNA ventrally coinjected embryos (Lâ²â²) are shown in vegetal view, dorsal side up at stage 10.5. The expression of Xhex (F,Fâ²), Xdkk1 (G,Gâ²), chordin (I, Iâ²), and Xnot (J,Jâ²) is repressed by Xhairy2b (green arrowheads), whereas that of cerberus (H,Hâ²) and noggin (K,Kâ²) is not affected by Xhairy2b. Light blue staining is coinjected β-gal. These genes are ventrally induced by β-catenin expression (red arrowheads in L). The ectopic expression of Xhex (Lâ²), Xdkk1 (Mâ²), chordin (Oâ²), and Xnot (Pâ²) is repressed by Xhairy2b coexpression with β-catenin (green arrowheads). Meanwhile, the expression of cerberus (Nâ²) and noggin (Qâ²) is not affected (red arrowheads).
|
|
Figure 4. Comparison of the expression domain of Xhairy2b with that of anterior endodermal genes and chordamesodermal genes at the early gastrula stage. A: Neighboring sections in the mid-sagittal plane of stage 10.5 embryos. Dorsal is to the right. Arrowheads indicate the blastopore lip. B,D,F:Xhairy2b is expressed in the ectoderm and the deep layer of the dorsal blastopore lip at the early gastrula stage. A,C: The expression of Xhex (A) and Xdkk1 (C) in the anterior endoderm is hardly overlapped with the expression of Xhairy2b. E: The expression of chordin in the deep layer of the organizer is overlapped with that of Xhairy2b.
|
|
Figure 5. Xhairy2b morpholino oligonucleotide (mo) specificity and change of axial mesoderm in Xhairy2b-depleted embryos. A: Alignment of the injected Xhairy2b mRNA constructs and morpholino oligos (1: five-mismatch control mo; 2: Xhairy2b mo). Xhairy2byc Tag (MT) constructs (3) contain the 5â²-untranslated region binding site for the Xhairy2b morpholino, whereas the -mo Xhairy2bT constructs (4) do not. B: Western blot analysis of Xhairy2bT. The efficacy of the morpholinos is tested by blocking the in vivo translation of Xhairy2bT mRNA and morpholino-injected embryos. Uninjected control (lane 1) and embryos injected with Xhairy2bT mRNA (lane 2), Xhairy2bT mRNA+five-mismatch control mo (lane 3), Xhairy2bT mRNA+Xhairy2b mo (lane 4), -mo Xhairy2bT mRNA (lane 5), or -mo Xhairy2bT mRNA+Xhairy2b mo (lane 6). The translation of Xhairy2bT is repressed by coinjecting Xhairy2b mo but not the five-mismatch control mo. On the other hand, the translation of -mo Xhairy2b mo, which does not contain the morpholino binding site, is not suppressed by Xhairy2b mo. Coomassie staining of the cell pellets served as a loading control. C,Câ²: In situ hybridization of chordin and pax2 in control mo-injected embryo (C) and Xhairy2b morpholino antisense oligo-injected embryo (Câ²) at stage 13. The expression of chordin is expanded in the mo-injected embryo. Dorsal view and anterior to the top. Dâ²: Neighboring section in the mid-sagittal plane of control mo-injected embryo (D,E) and Xhairy2b mo-injected embryo (Dâ²,Eâ²). At the early neurula stage, the mesodermal expression of Xhairy2b is restricted to the anterior prechordal mesoderm and is distinct from the expression of chordin. In the mo-injected embryo, the expression of chordin (Dâ²) and Xhairy2b (Eâ²) is overlapped in the anterior prechordal mesoderm. Arrowheads indicate the posterior limits of Xhairy2b expression in the axial mesoderm. Anterior is to the left. F,Fâ²:goosecoid expression in control mo-injected (F) and Xhairy2b mo-injected (Fâ²) embryos. The goosecoid expression is significantly decreased in Xhairy2b mo-injected embryo. Light blue staining is in situ hybridization for coinjected YFP mRNA. Gâ²: Mid-sagittal section of stage 14 control mo-injected embryo (G) and Xhairy2b mo-injected embryo (Gâ²â²). Anterior is to the left. Prechordal mesoderm-specific goosecoid expression is decreased in the posterior region (G,Gâ²) and chordamesoderm-specific Xbra and Xnot expression is anteriorly increased (Hâ²). Arrowheads indicate the limit of the gene expression domain. The dotted line is the border between the anterior neuroectoderm and the prechordal mesoderm. J: Schematic diagram of the axial mesodermal tissue in Xhairy2b mo-injected embryo. Anterior prechordal mesoderm (apm) is decreased, and the region of the posterior prechordal mesoderm (ppm) and the notochord (nc) is anteriorly expanded.
|